Personalized treatment through a Dry Powder inhaler device (DPI), adjustable to Chronic Obstructive Pulmonary Disease (COPD) patient′s respiratory profile

被引：0
|
作者：
Zarogoulidis, Konstantinos [1 ]
Michailidis, Nikolaos [1 ]
Siopi, Dimitra [2 ]
Tsiouda, Theodora [3 ]
Theodoridou, Anatoli [3 ]
Koltsida, Ourania [4 ]
Rapti, Aggeliki [4 ]
Petridis, Dimitrios [5 ]
Porpodis, Konstantinos [1 ]
Babalis, Georgios [2 ]
Petanidis, Savvas [1 ]
Chloros, Diamantis [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Thessaloniki, Greece
[2] G Papanikolaou Gen Hosp, Thessaloniki, Greece
[3] Theageneio Anticanc Hosp, Thessaloniki, Greece
[4] Sotiria Gen Hosp, Athens, Greece
[5] Int Hellenic Univ, Thessaloniki, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA545
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] INHALATION CHARACTERISTICS WITH SPIROMAX® AND TURBUHALER® DRY POWDER INHALERS (DPI) IN HEALTHY ADULTS AND PATIENTS WITH ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): BEFORE AND AFTER ENHANCED TRAINING
    Chrystyn, H.
    Azouz, W.
    Chetcuti, P.
    Hosker, H.
    Saralaya, D.
    THORAX, 2013, 68 : A178 - A179
  • [32] ECONOMIC EVALUATION OF TIOTROPIUM/OLODATEROL ADMINISTRATED THROUGH THE RESPIMAT INHALER AS MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN POLAND
    Pawlik, M.
    Karwala, P.
    Zyla, A.
    Parkitny, M.
    Walczak, J.
    Pieniazek, I
    Augustynska, J.
    Zawodnik, A.
    VALUE IN HEALTH, 2016, 19 (07) : A554 - A554
  • [33] An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease
    Hogan, TJ
    Geddes, R
    Gonzalez, ER
    CLINICAL THERAPEUTICS, 2003, 25 (01) : 285 - 297
  • [34] Aclidinium bromide/formoterol fumarate dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease in the EU
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2015, 31 (6) : 183 - 189
  • [35] PREFERENCES FOR DRY POWDER INHALER ATTRIBUTES AMONG PATIENTS WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE FROM FIVE EUROPEAN COUNTRIES
    Hawken, N. A.
    Amri, I
    Neine, Elmoctar M.
    Aballea, S.
    Torvinen, S.
    Plich, A.
    VALUE IN HEALTH, 2015, 18 (07) : A364 - A364
  • [36] Quantifying The Severity Of Respiratory Symptoms Of Chronic Obstructive Pulmonary Disease (COPD): Reliability And Validity Of A Patient Diary
    Sexton, C. C.
    Leidy, N. K.
    Notte, S. M.
    Jones, P.
    Monz, B. U.
    Nelsen, L.
    Ramachandran, S.
    Sethi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [37] Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease
    Cazzola, M
    D'Amato, M
    Califano, C
    Di Perna, F
    Calderaro, F
    Matera, MG
    D'Amato, G
    CLINICAL THERAPEUTICS, 2002, 24 (04) : 595 - 604
  • [38] Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
    Brian R. Leaker
    Dave Singh
    Grant C. Nicholson
    Blanka Hezelova
    Thomas Goodin
    Ayca Ozol-Godfrey
    Gerald Galluppi
    Peter J. Barnes
    Respiratory Research, 20
  • [39] IDENTIFICATION OF DRY POWDER INHALER ATTRIBUTES, AND THEIR RELATIVE IMPORTANCE TO ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS, TO INFORM A DISCRETE CHOICE EXPERIMENT
    Hawken, N. A.
    Aballea, A. S.
    Torvinen, S.
    Plich, A.
    VALUE IN HEALTH, 2014, 17 (07) : A600 - A600
  • [40] Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease
    Siler, Thomas
    Jain, Renu
    Collison, Kathryn
    Sharma, Raj I.
    Sutton, Laura
    Rees, Jamie
    Bernstein, David
    PLOS ONE, 2022, 17 (08):
12345